Oscar Health, Inc.
OSCR
$12.03
-$0.32-2.59%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -153.55M | -54.60M | 56.21M | 177.37M | -150.03M |
| Total Depreciation and Amortization | 9.23M | 7.50M | 7.60M | 7.81M | 7.74M |
| Total Amortization of Deferred Charges | 195.00K | 194.00K | 195.00K | 194.00K | 195.00K |
| Total Other Non-Cash Items | 17.10M | 22.37M | 22.76M | 18.75M | 36.39M |
| Change in Net Operating Assets | 473.84M | -475.60M | 410.39M | 430.24M | 402.57M |
| Cash from Operations | 346.82M | -500.14M | 497.15M | 634.36M | 296.87M |
| Capital Expenditure | -6.82M | -7.57M | -7.56M | -5.95M | -6.10M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.63M | -570.20M | -470.07M | -294.64M | 178.58M |
| Cash from Investing | -31.45M | -577.77M | -477.63M | -300.59M | 172.48M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.82M | 18.56M | 18.70M | 27.31M | 1.07M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.82M | 18.56M | 18.70M | 27.31M | 1.07M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 319.19M | -1.06B | 38.23M | 361.08M | 470.41M |